HLB Life Science Co., Ltd. (KOSDAQ:067630)
3,160.00
+80.00 (2.60%)
Aug 14, 2026, 3:30 PM KST
-22.36% (1Y)
| Market Cap | 385.04B -22.4% |
| Revenue (ttm) | 51.51B +46.5% |
| Net Income | -50.45B |
| EPS | -413.68 |
| Shares Out | 121.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 502,685 |
| Open | 3,080.00 |
| Previous Close | 3,080.00 |
| Day's Range | 3,050.00 - 3,340.00 |
| 52-Week Range | 1,608.00 - 5,330.00 |
| Beta | 0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |